VAXCYTE INC
PCVXNASDAQ🏆 #868 by market capEarnings Nov 9US Equity
$61.46▲ $0.79 (+1.30%)
🌅 Pre-market$64.14▲ 4.37%Regular close · extended-hours price shownTrack PCVX
Get earnings, price moves & breaking news on Telegram
24h▲ 1.3%
7d▼ 2.1%
14d▼ 5.8%
30d▲ 8.4%
ytd▲ 33.3%
1y▲ 41.5%
🏦Market Cap
$9.35B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
VAXCYTE INC
PCVXAnalyst Ratings
Price
$61.46
Total
11
Raised
0
Lowered
0
Avg PT
$122.33
H / L
$125 / $120
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Cantor Fitzgerald | Reiterated | Overweight | 2026-10-12 | $120.00 | +95.20% |
Guggenheim | Reiterated | Buy | 2026-10-05 | $125.00 | +103.40% |
BTIG | Reiterated | Buy | 2026-10-05 | $89.00 | +44.80% |
Needham | Reiterated | Buy | 2026-10-05 | $122.00 | +98.50% |
B of A Securities | Reiterated | Buy | 2026-09-28 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-01 | — | — |
Mizuho | Reiterated | Outperform | 2024-09-10 | — | — |
Jefferies | Reiterated | Buy | 2024-09-03 | $146.00 | +137.60% |
Leerink Partners | Reiterated | Outperform | 2024-09-03 | $77.00 | +25.30% |
TD Cowen | Reiterated | Outperform | 2023-04-18 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-12-16 | — | — |
Institution
Cantor Fitzgerald
Reiterated · Overweight · 2026-10-12
$120.00
+95.20%
Guggenheim
Reiterated · Buy · 2026-10-05
$125.00
+103.40%
BTIG
Reiterated · Buy · 2026-10-05
$89.00
+44.80%
Needham
Reiterated · Buy · 2026-10-05
$122.00
+98.50%
B of A Securities
Reiterated · Buy · 2026-09-28
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-01
—
—
Mizuho
Reiterated · Outperform · 2024-09-10
—
—
Jefferies
Reiterated · Buy · 2024-09-03
$146.00
+137.60%
Leerink Partners
Reiterated · Outperform · 2024-09-03
$77.00
+25.30%
TD Cowen
Reiterated · Outperform · 2023-04-18
—
—
SVB Leerink
Reiterated · Outperform · 2022-12-16
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space